{"database": "lobbying", "table": "lobbying_activities", "rows": [[2825792, "2e6731af-8c24-49c2-a17f-69d40304fb7c", "Q2", "FAEGRE DRINKER BIDDLE & REATH LLP", 12631, "NATIONAL ASSOCIATION OF BOARDS OF PHARMACY", 2022, "second_quarter", "PHA", "Medication safety, pharmacy regulation and licensure, and the opioid epidemic; Prescription drug monitoring programs; COVID-19 response; H.R.2482, S. 2074 - Mainstreaming Addiction Treatment Act; Prescription drug importation; H.R. 6352, S. 3399 - Domain Reform for Unlawful Drug Sellers Act.", "Drug Enforcement Administration (DEA),Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),SENATE", 50000, null, 0, 0, "2022-07-18T16:50:46-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2825792"], "units": {}, "query_ms": 5.432190839201212, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}